Upstream Bio, Inc. (UPB)
NASDAQ: UPB · Real-Time Price · USD
7.97
+0.60 (8.22%)
Mar 4, 2026, 2:45 PM EST - Market open
Upstream Bio Market Cap
Upstream Bio has a market cap or net worth of $430.42 million as of March 4, 2026. Its market cap has increased by 5.67% in one year.
Market Cap
430.42M
Enterprise Value
40.77M
1-Year Change
5.67%
Ranking
Category
Stock Price
$7.97
Market Cap Chart
Since the IPO on October 11, 2024, Upstream Bio's market cap has increased from $393.35M to $430.42M, an increase of 9.42%. That is a compound annual growth rate of 6.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 397.72M | -72.89% |
| Dec 31, 2025 | 1.47B | 66.51% |
| Dec 31, 2024 | 881.13M | 124.01% |
| Oct 11, 2024 | 393.35M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Armata Pharmaceuticals | 413.58M |
| DiaMedica Therapeutics | 413.09M |
| LENZ Therapeutics | 411.46M |
| Century Therapeutics | 409.60M |
| Keros Therapeutics | 408.25M |
| PureTech Health | 397.82M |
| Aura Biosciences | 396.26M |
| Cybin | 395.28M |